Abstract
Background The objective of this study was to update malaria epidemiological profile prior to the implementation of a randomized controlled trial aiming to evaluate the efficacy of new vector control tools in complementary to the use of long-lasting insecticidal nets in Burkina Faso.
Methods We carried out active and passive cross-sectional surveys to estimate the prevalence and incidence of malaria infection from August 2016 to July 2017 in 27 villages of the Diebougou health district.
Results With the passive survey, we extracted data from 4814 patients included in the study from August 2016 to July 2017. Malaria incidence showed a seasonal distribution, with an overall incidence rate estimated at 414.3 per 1000 person-years. In the active cross sectional surveys, we enrolled 2839, 2594 and 2337 participants respectively in September 2016, December 2016 and June 2017. Prevalence of malaria infection were respectively 41.5%, 43.5% and 32.3% in September 2016, in December 2016 and June 2017. Multivariate analysis showed that girls seemed to have a lower risk of malaria infection (OR = 0.86; 95% CI = 0.79 - 0.95; p = 0.004). The risk of malaria infection was significantly lower in third survey (June 2017) at the beginning of the rainy season (OR = 0.69; 95% CI = 0.6 - 0.8; p < 0.001) compared to the first survey (September 2016) which was performed during the rainy season. Children aged 6 to 59 months had a higher risk of malaria infection compared to those aged 10 to 17 years (OR = 0.58; 95% CI = 0.51 - 0.66).
Conclusion Malaria burden remains high in this region of Burkina Faso despite substantial efforts made in malaria control during this current decade. Children under 5 years old were subject of malaria burden in this setting. This results reinforce the urgent need to develop alternative control strategies to complement those already existing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was part of the REACT project, funded by the French Initiative 5 % Expertise France (N 15SANIN213).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Institutional Ethics Committee for Health Research of the Institut de Recherche en Sciences de la Sante (Reference number 06-2016/CEIRES). Written informed consents were obtained from all parents or guardians of children who participated in the study. Participants were explaining the full scope of the study and their right to participate or not without any prejudice; participation could be stopped at any time without any explanation. Subjects diagnosed with malaria were treated in accordance with the National Malaria Control Program guideline.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets used during this article are available at the Institut de Recherche en Sciences de la Sante, Bobo-Dioulasso, Burkina Faso and will be made easily available on request, when required.
